How much cash did Learningrx pay for interest in 2024?
Learningrx Franchise · 2025 FDDAnswer from 2025 FDD Document
218,958 | 220,053 | | | Net Other Noncurrent Assets | 377,410 | 375,880 | | | Total Assets | $ 1,433,773 | | $ 1,193,151 |
LearningRx Franchise Corporation Statements of Cash Flows For the Years Ended September 30, 2024 and 2023
| 2024 | 2023 | ||
|---|---|---|---|
| Cash Flows from Operating Activities | |||
| Net income | $ | 169,308 | $ 7,181 |
| Depreciation | 898 | 898 | |
| Changes in assets and liabilities: | |||
| Accounts receivable, net | (6,717) | 3,437 | |
| Prepaid expenses | (1,806) | 1,635 | |
| Deferred income tax asset | 240 | 11,350 | |
| Accounts payable | 35,427 | 5,871 | |
| Liability for marketing and development | 36,982 | 14,328 | |
| Deferred franchise fee revenue | - | (28,000) | |
| Right-of-use asset | 1,096 | (220,053) | |
| Lease obligations | (1,096) | 220,053 | |
| Net Cash Provided by Operations | 234,332 | 16,700 | |
| Increase in Cash and Cash Equivalents | 234,332 |
Source: Item 23 — RECEIPT (FDD pages 54–209)
What This Means (2025 FDD)
According to Learningrx's 2025 Franchise Disclosure Document, the company paid $0 in cash for interest during the year ending September 30, 2024. This information is derived from the statement of cash flows, which provides a summary of the cash inflows and outflows for Learningrx during the specified period.
For a prospective franchisee, this indicates that Learningrx had no recorded cash outflow for interest payments during this period. This could be due to various factors, such as having no debt obligations requiring interest payments or having structured its financing in a way that interest expenses were accounted for differently.
It is important to note that this figure reflects the cash paid for interest and may not represent the total interest expense incurred by Learningrx, as some interest expenses may be non-cash items or accrued but not yet paid. Additionally, the financial statements are for the period ending September 30, 2024, and may not be indicative of future performance or cash flow patterns.
Franchisees should consider this information in the context of the overall financial health and performance of Learningrx, and consult with financial advisors to fully understand the implications of these figures.